Presentation TCT 2017 Is There a Role for Dedicated Stents for the Left Main Bifurcation? Rationale and Device Landscape (With Case Examples) Presenter: David Hildick-Smith, Jeffrey W. Moses, Carlo Briguori October 31, 2017
Presentation TCT 2017 Coronary Stents for Left Main PCI: Considerations on Design and Selection, With Bench Examples Presenter: David Hildick-Smith, Jeffrey W. Moses, Nicolas Foin October 31, 2017
Presentation TCT 2017 Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update Presenter: Manel Sabate, Joanna J. Wykrzykowska, Qi Zhang October 31, 2017
Presentation TCT 2017 Buma Stent: Device Specifications, Clinical Trial Results, and Global Development Presenter: Manel Sabate, Joanna J. Wykrzykowska, Kefei Dou October 31, 2017
Presentation TCT 2017 Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development Presenter: Manel Sabate, Joanna J. Wykrzykowska, Luca Testa October 31, 2017
Presentation TCT 2017 The DESyne Novolimus-Eluting Coronary Stent: Results From the Excella Trials Presenter: Manel Sabate, Joanna J. Wykrzykowska, Javaid Iqbal October 31, 2017
Presentation TCT 2017 Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 2: Inspiron Presenter: Manel Sabate, Joanna J. Wykrzykowska, Pedro A. Lemos October 31, 2017
Presentation TCT 2017 Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 1: Biomime Presenter: Manel Sabate, Joanna J. Wykrzykowska, Roberto Botelho October 31, 2017
Presentation TCT 2017 The Combo Stent: From Concept to Clinical Performance Presenter: Manel Sabate, Joanna J. Wykrzykowska, Roxana Mehran October 31, 2017
News Conference News TCT 2017 Long-term Absorb BVS Data Continue to Disappoint Michael O'Riordan October 31, 2017
Presentation TCT 2017 Optimal Technique: Radial vs Femoral Access, and Optimizing Patency With Covered vs Bare Metal Stents Presenter: D. Christopher Metzger, Ido Weinberg October 31, 2017
Presentation TCT 2017 TCT 58: Biomechanics and Drug Elution in Arterial Response to Peripheral Stents: A Comparative Study of 3 Contemporary Stents in Balloon-Predilated Femoral Arteries of Familial Hypercholesterolemic Swine Presenter: Sahil A. Parikh, Yanping Cheng, MD October 31, 2017
Presentation TCT 2017 Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR Presenter: Nick Curzen, Rod H. Stables October 31, 2017
Presentation TCT 2017 DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB Presenter: Robert A. Byrne, Ran Kornowski, Juan F. Granada October 30, 2017
News Conference News TCT 2017 No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS Michael O'Riordan October 30, 2017
Presentation TCT 2017 Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman October 30, 2017
News Conference News TCT 2017 DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis Todd Neale October 30, 2017
Presentation TCT 2017 Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso October 30, 2017
Presentation TCT 2017 Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow? Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese October 30, 2017
Presentation TCT 2017 Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art Presenter: Robert A. Byrne, Ran Kornowski, Bruno Scheller October 30, 2017